LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy?

LENZ Therapeutics, Inc. (LENZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991q226pressrelease.htm EX-99.1 Document Exhibit 99.1 LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Q2 2026 total revenue of $5.5 million from VIZZ product sales and global license agreements Strong patient persistence,

Nebius reported Q4 FY25 revenue up 547% YoY and guided Q1 FY26 revenue growth of 684%. For FY26, it expects revenue of $3.0B to $3.4B and ARR of $7B to $9B, with adjusted EBITDA guidance of 40%. The company said it ended Q1 with $9.3B cash and has $40B contracted revenue from customers including Microsoft and Meta. Analysts rate NBIS “Moderate Buy” with a $252.07 mean target.

According to NewsWire, NSW Premier Chris Minns and federal PM Anthony Albanese are set to sign a bailout agreement with Rio Tinto for the Tomago aluminium smelter in Hunter Valley. Rio Tinto, which has a majority stake, warned it may shut Tomago if affordable long term power is not secured by 2028. The plan may involve Snowy Hydro 2.0 underwriting renewable power costing over $300m per year for 10 years.

Phillips 66, Kinder Morgan and HF Sinclair said they made a final investment decision to proceed with the $5 billion Western Gateway Pipeline, aiming for completion in 2029 subject to permits. The 1,300-mile system would move refined fuels into the West with 230,000 bpd capacity and potential Southern California gasoline price relief. Ownership: Phillips 66 49.9%, Kinder Morgan 35.1%, HF Sinclair 15%.

Glenmark Pharmaceuticals’ U.S. unit said, in an exchange filing, it reached a settlement with Humana to resolve antitrust litigation tied to consolidated generic-drug price-fixing claims in the Eastern District of Pennsylvania. The settlement totals $15.28 million plus interest, paid in two installments. Glenmark denied the allegations and said the amount was already booked in its financial statements.

Boeing said the US Air Force awarded it a $75 million undefinitized contract action to start building the GBU-75 long-range guided bomb, combining a JDAM warhead with a wing kit and turbojet engine to reach over 300 nautical miles. Boeing invested nearly $100 million. The Navy plans initial deliveries after April 2026 tests.